Gleneagles Hospital Hong Kong marked the beginning of its local antimicrobial resistance (AMR) programme with a pledge to promote the responsible use of antibiotics and help raise public awareness of AMR.
Led by its CEO Dr Kenneth Tsang, the hospital departments showed their support by pledging to use antibiotics responsibly.
As part of IHH’s sustainability commitment to Care for Public, all IHH hospitals will implement antimicrobial resistance interventions in line with CDC, WHO and national guidelines by 2025.
Related Stories
Gleneagles BGS Champions Spine Health and Recovery
Gleneagles BGS Hospital brought together patients, clinicians and spine health advocates to celebrate life after spinal surgery while raising awareness of early diagnosis and timely intervention.
Pantai KL Brings Cancer Care Closer to More Communities
Pantai Hospital Kuala Lumpur has strengthened its oncology services with the soft launch of the Pantai Oncology Daycare Centre in Cheras, bringing cancer treatment closer to patients and families.
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
Turning Clinical Insights into Better Patient Outcomes
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
